Hyperosmolar oxyreplete hemosubstitute

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530385, 514 6, 514832, 514833, 514 23, 514 60, 514769, 514777, A61K 3166, A61K 3170

Patent

active

051149320

ABSTRACT:
New blood substitutes are described having osmolarities greater than normal blood. The new blood substitues typically comprise a physiologically acceptable fluid electrolyte solution, a physiologically acceptable agent capable of increasing the osmolarity of the blood substitute to a value greater than normal blood, an oxygen carrying substance, and a sufficient amount of water to achieve the desired osmolarity. The blood substitutes of the present invention have osmolarities in the range of 500-800 milliosmoles per liter.

REFERENCES:
patent: 3679795 (1972-07-01), DeSomer et al.
patent: 3911915 (1975-10-01), Seifter et al.
patent: 3928574 (1975-12-01), Phillips
patent: 3937821 (1976-02-01), Irikura et al.
patent: 4740594 (1988-04-01), Mauzac et al.
patent: 4757052 (1988-07-01), Markov
patent: 4866096 (1989-09-01), Schweighardt
patent: 4873230 (1989-10-01), Belzer et al.
patent: 4908350 (1990-03-01), Kramer et al.
patent: 4927806 (1990-05-01), Kramer et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hyperosmolar oxyreplete hemosubstitute does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hyperosmolar oxyreplete hemosubstitute, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyperosmolar oxyreplete hemosubstitute will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2417571

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.